Loss of HER2 and disease prognosis after neoadjuvant treatment of HER2+ breast cancer.
Branco FP, Machado D, Silva FF, André S, Catarino A, Madureira R, Pinto JM, Godinho JP, Simões PD, Brito M, Casa-Nova M, Moreira AR, Passos-Coelho JL.
Branco FP, et al. Among authors: passos coelho jl.
Am J Transl Res. 2019 Sep 15;11(9):6110-6116. eCollection 2019.
Am J Transl Res. 2019.
PMID: 31632579
Free PMC article.